Double Medical(SZ:002901) Xin Lang Cai Jing·2025-11-14 02:31Core Viewpoint - Dabo Medical has shown a significant increase in stock price and financial performance, indicating strong growth potential in the medical device sector [1][2]. Financial Performance - For the period from January to September 2025, Dabo Medical achieved a revenue of 1.876 billion yuan, representing a year-on-year growth of 22.69% [2]. - The net profit attributable to shareholders for the same period was 425 million yuan, reflecting a substantial year-on-year increase of 77.03% [2]. - Cumulative cash dividends since the A-share listing amount to 1.442 billion yuan, with 307 million yuan distributed over the past three years [3]. Stock Market Activity - As of November 14, Dabo Medical's stock price rose by 2.02% to 50.56 yuan per share, with a market capitalization of 20.933 billion yuan [1]. - The stock has increased by 66.60% year-to-date, with a recent 3.10% rise over the last five trading days [1]. - The company experienced a net inflow of main funds amounting to 1.8528 million yuan, with significant buying activity from large orders [1]. Shareholder Information - As of September 30, 2025, the number of shareholders increased by 17.38% to 22,800, while the average number of tradable shares per person decreased by 14.80% to 12,673 shares [2]. - The top ten circulating shareholders include significant institutional investors, with Hong Kong Central Clearing Limited being the fifth largest, increasing its holdings by 6.6836 million shares [3].